FUNCTIONAL & INTEGRATIVE GENOMICS, published by Springer Heidelberg, is a leading journal in the fields of genetics and molecular biology. Established in 2000, it serves as a pivotal platform for advancing our understanding of genomic functionality and integration, making significant contributions to both basic and applied research in genetics. With a robust impact factor and a ranking in the Q3 quartile for Genetics and Q2 for Medicine (Miscellaneous), the journal aims to publish innovative research that explores the relationships between genomic data and biological functions, appealing to a diverse audience of researchers and professionals. Although it operates under a subscription model, the journal's extensive archives remain a valuable resource for academics seeking to stay abreast of the latest findings and methodologies in genomics. As the field evolves, FUNCTIONAL & INTEGRATIVE GENOMICS remains committed to fostering scholarly dialogue and the dissemination of groundbreaking studies that influence future research trajectories.

AoB Plants is a distinguished open-access journal published by Oxford University Press, dedicated to advancing the field of plant science. Since its inception in 2009, this journal has played a pivotal role in disseminating high-quality research that encompasses a wide range of topics including plant biology, ecology, and biotechnology. With an impressive impact factor and a ranking in the Q1 quartile for Plant Science, AoB Plants is recognized for its innovative contributions and scholarly rigor, ranking #129 out of 516 in the Scopus Agricultural and Biological Sciences category, placing it in the 75th percentile among its peers. By promoting open-access availability of research findings, the journal empowers researchers and practitioners alike, facilitating greater collaboration and knowledge sharing in the global scientific community. Situated in the heart of the United Kingdom, AoB Plants continues its commitment to providing a platform for pioneering research and developments in plant science, thus fostering a deeper understanding of the crucial roles that plants play in our ecosystems and economies.

Evolutionary Bioinformatics, published by SAGE Publications Ltd, is a pioneering open-access journal established in 2005, dedicated to advancing the field of evolutionary biology through innovative computational techniques and bioinformatics. With an ISSN of 1176-9343, it serves as a critical platform for researchers, professionals, and students to disseminate impactful findings and foster collaboration across disciplines. The journal spans a broad scope, contributing significantly to the areas of Ecology, Evolution, Behavior and Systematics, and Genetics, as evidenced by its respectable Scopus rankings and quartile placements in 2023. With a commitment to providing comprehensive, peer-reviewed research articles and tools for sharing knowledge, Evolutionary Bioinformatics plays an essential role in shaping the future of evolutionary studies and bioinformatics. Readers and contributors alike are encouraged to engage with cutting-edge research that pushes the boundaries of understanding in this dynamic field.

OPHTHALMIC GENETICS is a distinguished journal published by TAYLOR & FRANCIS INC, specializing in the intersection of genetics and ophthalmology. Established in 1981, the journal has become a vital resource for researchers, clinicians, and students interested in the genetic aspects of eye diseases and disorders. Despite not being an Open Access journal, it maintains a commendable impact within the academic community, as reflected by its Q3 ranking in clinical genetics and Q2 rankings in both ophthalmology and pediatrics in 2023. With a robust focus on clinical applications, OPHTHALMIC GENETICS aims to provide a platform for innovative research and insights that drive advancements in patient care and understanding of genetic conditions affecting vision. The journal's international readership is supported by its timely publication of articles that bridge the gap between genetic research and practical ophthalmological applications.

HEREDITY is a prestigious academic journal published by SpringerNature, specializing in the dynamic fields of Genetics and Genetics (Clinical). With a history of excellence since its inception in 1947, this journal has established itself as a significant contributor to the understanding of genetic research, addressing both foundational principles and clinical applications. Operating without an open access model, it maintains a strong reputation with an impact factor that reflects its rigorous peer-review process and high-quality submissions, ranking in the top quartiles of its category as evidenced by its Q2 classification in Genetics and Genetics (clinical) for 2023. Further, HEREDITY holds commendable positions in Scopus rankings, illustrating its influence within the field, currently placed #21 out of 99 in Medicine (Clinical Genetics) and #87 out of 347 in Biochemistry, Genetics, and Molecular Biology (Genetics). Researchers, professionals, and students are invited to explore the latest discoveries and advancements in genetics through this esteemed journal, contributing to the broader discourse and innovation within the field.

BioData Mining is a distinguished open access journal published by BMC, focusing on the dynamic intersection of bioinformatics, computational mathematics, and molecular biology. Since its inception in 2008, this journal has provided a critical platform for researchers and professionals to publish their findings, contributing significantly to the collective knowledge in fields such as biochemistry, computational theory, and genetics. With a robust impact factor and a commendable h-index, BioData Mining continues to be a vital resource for academic and industrial advancements, ranked in the top quartiles in various categories according to the 2023 metrics. The journal's commitment to open access ensures that cutting-edge research is readily available to the global scientific community, thereby enhancing visibility and fostering collaboration among scholars. Whether you are a researcher, student, or practitioner, engaging with BioData Mining will equip you with relevant insights and developments in the fast-evolving realm of bioinformatics.

AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS is a premier peer-reviewed journal published by Wiley, focusing on the intricate and evolving field of medical genetics. With its ISSN 1552-4868 and E-ISSN 1552-4876, the journal has established itself as a significant resource for researchers, professionals, and students alike, addressing cutting-edge developments in genetic research and clinical practice. Ranked in the top quartile (Q2) in both Genetics and clinical Genetics categories for 2023, it maintains an impressive Scopus ranking, positioning it within the 75th and 71st percentiles for Medicine and Genetics respectively. The journal encourages open access to its content, promoting wider dissemination of knowledge and fostering collaboration among medical genetics experts. From its inaugural issues in 1980 to its ongoing publications, the journal aims to bridge the gap between genetics research and its clinical applications, providing insights that reflect the latest advancements in the field. As it continues to serve the global medical community, the AMERICAN JOURNAL OF MEDICAL GENETICS PART C remains a vital source for those seeking to understand the complexities of genetic disorders and their implications for health and disease.

Metabolites is a dynamic open-access journal published by MDPI that has been at the forefront of biochemistry, endocrinology, diabetes, and metabolism research since its inception in 2011. Based in Switzerland, this journal plays a crucial role in disseminating high-quality research, evident from its esteemed Q2 quartile rankings in biochemistry, endocrinology, and molecular biology categories for 2023. With an E-ISSN of 2218-1989, it provides essential insights into the metabolic processes underlying health and disease, thereby appealing to a diverse audience of researchers, professionals, and students dedicated to advancing knowledge in these critical fields. With its commitment to open access, Metabolites ensures that cutting-edge findings are readily available to the global scientific community, encouraging collaboration and innovation.

Current Bioinformatics, an esteemed journal published by Bentham Science Publishers Ltd, serves as a pivotal platform for the dissemination of cutting-edge research in the fields of bioinformatics, biochemistry, computational mathematics, genetics, and molecular biology. With an ISSN of 1574-8936 and an E-ISSN of 2212-392X, this journal has established itself as a vital resource for researchers, professionals, and students keen on exploring interdisciplinary approaches to biological data analysis. Its prominence is reflected in its quartile rankings for 2023, where it stands in Q3 for biochemistry and computational mathematics, alongside Q4 rankings in genetics and molecular biology. Current Bioinformatics, located in the United Arab Emirates and converging from 2007 to 2024, aims to foster innovation in the field by presenting original research articles, reviews, and case studies that drive forward our understanding of complex biological systems through computational techniques. This journal is an integral resource for those wishing to stay at the forefront of bioinformatics research and applications.

Annual Review of Biomedical Data Science, published by ANNUAL REVIEWS, stands as a premier journal in the fields of Biomedical Engineering, Biochemistry, Genetics, and Cancer Research, with an impressive Q1 ranking across these categories in 2023. With its ISSN and e-ISSN both assigned as 2574-3414, this journal serves as a critical resource for researchers, professionals, and students looking to delve into comprehensive reviews of the rapidly evolving landscape of biomedical data science. The journal's scope includes the intersection of data science methodologies and biomedical applications, making it essential for those aiming to stay at the forefront of innovations that drive advancements in healthcare and medical research. Although it currently does not provide open access options, its commitment to high-quality research and its robust rankings—placing it in the 94th percentile in its field—underscore its significance and credibility in the academic community. Operating from the United States, with its offices located in Palo Alto, CA, this journal is a vital contributor to the discourse on the integration of data science within biomedical fields, fostering collaboration and knowledge dissemination among scholars worldwide.